Clinical Scorecard: Telehealth Rehabilitation Utilizing AI for Seniors with Mild Cognitive Impairment: A Randomized Controlled Study
At a Glance
Category
Detail
Condition
Mild Cognitive Impairment (MCI), a transitional state to dementia
Key Mechanisms
AI-driven, self-guided, home-based cognitive rehabilitation with autonomous difficulty adjustment
Target Population
Older adults aged 65 years or older with MCI (K-MMSE2 score 18-26)
Care Setting
Home-based telerehabilitation using AI platform (Zenicog®)
Key Highlights
Intervention group showed significant improvement in global cognitive function (K-MMSE2 median 28.0 vs. 26.0; p < 0.001)
Clinical success (K-MMSE2 ≥27) achieved by 93.9% in intervention group vs. 0% in control
High usability and satisfaction scores (≥4.5/5) with no adverse events or dropouts
Guideline-Based Recommendations
Diagnosis
Identify MCI using standardized cognitive screening tools such as K-MMSE2 with scores between 18 and 26
Management
Implement AI-driven, self-guided telerehabilitation programs to improve global cognitive function in MCI patients
Use home-based computerized cognitive rehabilitation to overcome logistical barriers of clinic-based therapy
Monitoring & Follow-up
Monitor cognitive function primarily via global cognitive assessments (e.g., K-MMSE2)
Assess usability and patient satisfaction regularly to ensure adherence
Risks
No significant adverse events reported with AI-driven telerehabilitation in MCI patients
Minimal supervision required, reducing risks associated with clinic visits
Patient & Prescribing Data
Older adults with Mild Cognitive Impairment (K-MMSE2 18-26), aged 65 years or older
A 5-week home-based AI-driven cognitive rehabilitation program (24 sessions) significantly improves global cognitive function with high patient satisfaction and no adverse effects
Clinical Best Practices
Utilize AI algorithms to autonomously adjust cognitive task difficulty based on real-time performance data
Adopt telerehabilitation to enhance accessibility and adherence in elderly and frail populations
Ensure blinded randomization and concealed allocation in clinical trials evaluating cognitive interventions
Focus on global cognitive function as primary outcome measure in MCI rehabilitation studies
